The peritoneal micromilieu commits B cells to home to body cavities and the small intestine.

Abstract:

:The distinct combination of homing receptors such as selectins, chemokine receptors, and integrins directs the migration of lymphocytes throughout the body. Upon activation lymphocytes irreversibly switch their set of homing receptors, now guiding them to entirely different destinations. Here we report that exposure of naive B cells to the microenvironment of the peritoneal cavity modulates their migration propensities in the absence of antigenic stimulation. B1 and B2 cells isolated from the peritoneal cavity reenter this compartment more efficiently compared with splenic follicular B cells. Moreover, when kept in the peritoneal cavity splenic follicular B cells gain such increased capability to reenter this compartment. These altered migratory capacities are reflected by an up-regulation of the chemokine receptors CXCR4 and CXCR5 and beta7 integrin by the peritoneum-experienced splenic B cells, among which CXCR5 is instrumental in directing B cells into the peritoneal cavity. Moreover, intraperitoneal transfer of plasma blasts favors their migration into the small intestine presumably before class switch recombination occurs, demonstrating that a reconfigured transient migration pattern is not restricted to naive cells. In conclusion, these data demonstrate a hitherto unrecognized role for tissue-specific cues, altering the migratory capacity of B1, naive B2, as well as antigen-experienced B2 cells.

journal_name

Blood

journal_title

Blood

authors

Berberich S,Förster R,Pabst O

doi

10.1182/blood-2006-12-064345

subject

Has Abstract

pub_date

2007-06-01 00:00:00

pages

4627-34

issue

11

eissn

0006-4971

issn

1528-0020

pii

blood-2006-12-064345

journal_volume

109

pub_type

杂志文章

相关文献

BLOOD文献大全
  • The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis.

    abstract::Cancer is a leading cause of thrombosis. We identify a new procoagulant mechanism that contributes to thromboembolism in prostate cancer and allows for safe anticoagulation therapy development. Prostate cancer-mediated procoagulant activity was reduced in plasma in the absence of factor XII or its substrate of the int...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-01-622811

    authors: Nickel KF,Ronquist G,Langer F,Labberton L,Fuchs TA,Bokemeyer C,Sauter G,Graefen M,Mackman N,Stavrou EX,Ronquist G,Renné T

    更新日期:2015-09-10 00:00:00

  • Near-haploid and low-hypodiploid acute lymphoblastic leukemia: two distinct subtypes with consistently poor prognosis.

    abstract::Hypodiploidy <40 chromosomes is an uncommon genetic feature of acute lymphoblastic leukemia (ALL) in both children and adults. It has long been clear by cytogenetic analyses, and recently confirmed by mutational profiling, that these cases may be further subdivided into 2 subtypes: near-haploid ALL with 24 to 30 chrom...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-10-743765

    authors: Safavi S,Paulsson K

    更新日期:2017-01-26 00:00:00

  • Alpha4beta1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells.

    abstract::As B-cell chronic lymphocytic leukemia (B-CLL) progresses, malignant cells extravasate and infiltrate lymphoid tissues. Several molecules, including gelatinase B/MMP-9, contribute to these processes. Although mainly a secreted protease, some MMP-9 is present at the B-CLL cell surface and the function, mode of anchorin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-08-109249

    authors: Redondo-Muñoz J,Ugarte-Berzal E,García-Marco JA,del Cerro MH,Van den Steen PE,Opdenakker G,Terol MJ,García-Pardo A

    更新日期:2008-07-01 00:00:00

  • MicroRNA regulation of STAT4 protein expression: rapid and sensitive modulation of IL-12 signaling in human natural killer cells.

    abstract::IL-12 exerts several regulatory effects on natural killer (NK) cells by activating IL-12 signaling. IL-12 signaling is tightly auto-regulated to control its onset and termination, with prolonged IL-12 treatment resulting in IL-12 hyporesponsiveness. However, the mechanisms underlying IL-12 auto-regulation are still un...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-05-356162

    authors: Huang Y,Lei Y,Zhang H,Hou L,Zhang M,Dayton AI

    更新日期:2011-12-22 00:00:00

  • Adaptive response of iron absorption to anemia, increased erythropoiesis, iron deficiency, and iron loading in beta2-microglobulin knockout mice.

    abstract::Recently, a novel gene of the major histocompatibility complex (MHC) class I family, HFE (HLA-H), has been found to be mutated in a large proportion of hereditary hemochromatosis (HH) patients. Further support for a causative role of HFE in this disease comes from the observation that beta2-microglobulin knockout (bet...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Santos M,Clevers H,de Sousa M,Marx JJ

    更新日期:1998-04-15 00:00:00

  • Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia.

    abstract::Regulatory T (Tr) cells have the potential to treat immune-mediated disease, but cloning such cells for study from patients with autoimmune disease has proven difficult. Here, we describe autoantigen-specific, interleukin-10 (IL-10)-secreting Tr cell clones recovered ex vivo from a patient with autoimmune hemolytic an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-07-101345

    authors: Ward FJ,Hall AM,Cairns LS,Leggat AS,Urbaniak SJ,Vickers MA,Barker RN

    更新日期:2008-01-15 00:00:00

  • Analysis of leukocyte differentiation antigens in blood and bone marrow from preleukemia (refractory anemia) patients using monoclonal antibodies.

    abstract::Peripheral blood and bone marrow mononuclear cells from patients with refractory anemia (RA) or RA with sideroblasts (defined according to the revised French-American-British classification with less than 5% blast cells in the bone marrow) were analyzed using a panel of monoclonal antibodies directed against leukocyte...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hokland P,Kerndrup G,Griffin JD,Ellegaard J

    更新日期:1986-04-01 00:00:00

  • Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay.

    abstract::A Y-chromosome-specific in situ hybridization assay was used to assess the frequency with which host bone marrow cells are retained after marrow grafting. The majority of patients (74%) showed the presence of both host and donor marrow cells when assayed 14 days after transplant. By 84 days posttransplant only 4% of t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Durnam DM,Anders KR,Fisher L,O'Quigley J,Bryant EM,Thomas ED

    更新日期:1989-11-01 00:00:00

  • Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy.

    abstract::Chronic myeloid leukemia (CML) with T315I mutation has been reported to have poor prognosis. We analyzed 27 patients with T315I, including 20 who developed T315I after imatinib failure (representing 11% of 186 patients with imatinib failure), and 7 of 23 who developed new mutations after second tyrosine kinase inhibit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-11-123950

    authors: Jabbour E,Kantarjian H,Jones D,Breeden M,Garcia-Manero G,O'Brien S,Ravandi F,Borthakur G,Cortes J

    更新日期:2008-07-01 00:00:00

  • Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion.

    abstract::The present studies were undertaken to determine whether factor VIII/von Willebrand factor (vWF) present in the vessel wall (in addition to that in plasma) may mediate the attachment of platelets to subendothelium. Subendothelium from everted rabbit aorta was exposed to human citrated blood flowing through an annular ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Turitto VT,Weiss HJ,Zimmerman TS,Sussman II

    更新日期:1985-04-01 00:00:00

  • Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells.

    abstract::Evidence has been provided recently that shows that high concentrations of cytokines can fulfill functions previously attributed to stromal cells, such as promote the survival of, and led to a net increase in human primitive progenitors initiating long-term cultures in vitro (LTC-IC) or engrafting NOD-SCID (nonobese d...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bennaceur-Griscelli A,Tourino C,Izac B,Vainchenker W,Coulombel L

    更新日期:1999-07-15 00:00:00

  • Sequential analysis of hematopoietic reconstitution achieved by transplantation of hematopoietic stem cells.

    abstract::We confirmed that murine hematopoietic stem cells express the c-kit molecule but not lymphohematopoietic lineage markers. These lineage marker-negative c-kit-positive (Lin- c-kit+) cells were further divided according to the uptake of rhodamine-123 (Rh-123). Approximately 1,000 Lin- c-kit+ rhodamine-123dull cells, whi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Okada S,Nagayoshi K,Nakauchi H,Nishikawa S,Miura Y,Suda T

    更新日期:1993-04-01 00:00:00

  • Development of a vascular niche platform for expansion of repopulating human cord blood stem and progenitor cells.

    abstract::Transplantation of ex vivo expanded human umbilical cord blood cells (hCB) only partially enhances the hematopoietic recovery after myelosuppressive therapy. Incubation of hCB with optimal combinations of cytokines and niche cells, such as endothelial cells (ECs), could augment the efficiency of hCB expansion. We have...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-12-398115

    authors: Butler JM,Gars EJ,James DJ,Nolan DJ,Scandura JM,Rafii S

    更新日期:2012-08-09 00:00:00

  • Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia.

    abstract::Mutations in the kinase domain (KD) of BCR-ABL are the most prevalent mechanism of acquired imatinib resistance in patients with chronic myeloid leukemia (CML). Here we examine predisposing factors underlying acquisition of KD mutations, evidence for acquisition of mutations before and during therapy, and whether the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-03-066936

    authors: O'Hare T,Eide CA,Deininger MW

    更新日期:2007-10-01 00:00:00

  • Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa.

    abstract::Because free factor VIIa is inactivated only very slowly by a plasma concentration of antithrombin III (AT III) even in the presence of heparin, it has been assumed that AT III plays no significant role in regulating the initiation of tissue factor-dependent blood coagulation. However, in the present study, we present...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rao LV,Rapaport SI,Hoang AD

    更新日期:1993-05-15 00:00:00

  • Treatment of refractory adult lymphoblastic leukemia (ALL) with 4'(9-acridinylamino) methanesulfon-M-anisidide (AMSA).

    abstract::Twenty-four adults with ALL were treated with AMSA alone or in combination. Twenty-two were treated at time of relapse and two patients after failing primary induction therapy. All had been treated with anthracyclines prior to receiving AMSA. Of the 22 patients with ALL in relapse, 4 achieved a complete remission. Two...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Arlin ZA,Fanucchi MP,Gee TS,Kempin SJ,Mertelsmann R,Young CW,Clarkson BD

    更新日期:1982-11-01 00:00:00

  • Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas.

    abstract::Primary cutaneous lymphomas have been successfully treated with interferons (IFNs), counterbalancing the T-helper 2 (Th2)-skewing state. We undertook a phase 1, open-label, dose-escalating trial of repeated intratumoral administration of TG1042 in patients with advanced primary cutaneous T-cell lymphomas (CTCLs) and m...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2004-01-0360

    authors: Dummer R,Hassel JC,Fellenberg F,Eichmüller S,Maier T,Slos P,Acres B,Bleuzen P,Bataille V,Squiban P,Burg G,Urosevic M

    更新日期:2004-09-15 00:00:00

  • Immunochemical characterization of rhesus proteins with antibodies raised against synthetic peptides.

    abstract::Rabbit polyclonal antibodies were raised against synthetic peptides corresponding to hydrophilic regions of the human Rhesus (Rh) IX cDNA-encoded polypeptide predicted to be extracellularly or intracellularly exposed in the topologic model of the Rh blood group protein. Four antibodies encompassing residues 33-45 (MPC...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hermand P,Mouro I,Huet M,Bloy C,Suyama K,Goldstein J,Cartron JP,Bailly P

    更新日期:1993-07-15 00:00:00

  • A novel role for PECAM-1 in megakaryocytokinesis and recovery of platelet counts in thrombocytopenic mice.

    abstract::During thrombopoiesis, maturing megakaryocytes (MKs) migrate within the complex bone marrow stromal microenvironment from the proliferative osteoblastic niche to the capillary-rich vascular niche where proplatelet formation and platelet release occurs. This physiologic process involves proliferation, differentiation, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-10-050740

    authors: Dhanjal TS,Pendaries C,Ross EA,Larson MK,Protty MB,Buckley CD,Watson SP

    更新日期:2007-05-15 00:00:00

  • Activation of the mitogen-activated protein kinase pathway is involved in and sufficient for megakaryocytic differentiation of CMK cells.

    abstract::Activation of the mitogen-activated protein (MAP) kinase pathway has been associated with both cell proliferation and differentiation. Constitutively activated forms of Mek (MAP kinase/Erk kinase) and Erk (MAP kinase) have been previously shown capable of inducing differentiation or proliferation in nonhematopoietic c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Melemed AS,Ryder JW,Vik TA

    更新日期:1997-11-01 00:00:00

  • Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo.

    abstract::Measurement of plasma levels of two secreted platelet proteins (beta-thromboglobulin and platelet factor 4) has been suggested as a means for detecting increased platelet activation in vivo. A crucial question in the measurement is the distinction between in vivo and in vitro secretion of the proteins. One approach to...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: Kaplan KL,Owen J

    更新日期:1981-02-01 00:00:00

  • How I manage the toxicities of myeloma drugs.

    abstract::The treatment of multiple myeloma is considered a continuously evolving paradigm as a result of the growing availability of new and highly effective drugs, including first- and second-generation proteasome inhibitors, immunomodulatory agents, and monoclonal antibodies. Clinical trials advocate long-term rather than sh...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-01-725705

    authors: Delforge M,Ludwig H

    更新日期:2017-04-27 00:00:00

  • Killer cell activity of human monoblastic leukemia cells as detected with a monocyte-specific target cell.

    abstract::Peripheral blood leukemia cells from patients with acute monoblastic leukemia (AMoL) were tested for killer cell activity against target cells that detected natural killer cell-mediated or monocyte-mediated spontaneous cytotoxicity. The fibrosarcoma cell line Wehi 164, pretreated with actinomycin D to induce susceptib...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ziegler-Heitbrock HW,Munker R,Thiel E,Krebs I,Riethmüller G

    更新日期:1985-01-01 00:00:00

  • Unusual deletions within the immunoglobulin heavy-chain locus in acute leukemias.

    abstract::We have investigated the structure of the Ig heavy (IGH) chain locus in 309 cases of acute leukemia. Seventy-one cases of B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) were analyzed: in six cases deletion of joining (JH) segments in the presence of cytogenetically normal chromosome 14 was observed. Similar...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dyer MJ,Heward JM,Zani VJ,Buccheri V,Catovsky D

    更新日期:1993-08-01 00:00:00

  • Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma.

    abstract::Interleukin-15 (IL-15) induces proliferation and promotes cell survival of human T and B lymphocytes, natural killer cells, and neutrophils. Here we report the constitutive expression of a functional IL-15 receptor (IL-15R) in 6 of 6 myeloma cell lines and in CD38(high)/CD45(low )plasma cells belonging to 14 of 14 pat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tinhofer I,Marschitz I,Henn T,Egle A,Greil R

    更新日期:2000-01-15 00:00:00

  • Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers.

    abstract::Hematide is an investigational pegylated synthetic peptide that stimulates erythropoiesis in animal models and is being developed for the treatment of anemia associated with chronic renal failure and cancer. This study evaluated the safety and pharmacodynamics of single, intravenous doses (0.025, 0.05, and 0.1 mg/kg) ...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2006-04-015818

    authors: Stead RB,Lambert J,Wessels D,Iwashita JS,Leuther KK,Woodburn KW,Schatz PJ,Okamoto DM,Naso R,Duliege AM

    更新日期:2006-09-15 00:00:00

  • Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disea

    abstract::T cell-depleted haploidentical hematopoietic stem cell transplantation (haploHSCT) is an option to treat children with very high-risk acute lymphoblastic leukemia (ALL) lacking an HLA-identical donor. We analyzed 127 children with ALL who underwent haploHSCT in first (n = 22), second (n = 48), or third (n = 32), compl...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2009-03-207001

    authors: Klingebiel T,Cornish J,Labopin M,Locatelli F,Darbyshire P,Handgretinger R,Balduzzi A,Owoc-Lempach J,Fagioli F,Or R,Peters C,Aversa F,Polge E,Dini G,Rocha V,Pediatric Diseases and Acute Leukemia Working Parties of the Europe

    更新日期:2010-04-29 00:00:00

  • Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A.

    abstract::It is currently debated whether the mechanism of action of therapeutic doses of recombinant factor VIIa (rFVIIa, Novo-Seven) relies on the tissue factor (TF)-independent activity of the enzyme. The present study was conducted to investigate the in vivo hemostatic effects of rFVIIa and 3 analogs thereof with superior i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-05-1369

    authors: Tranholm M,Kristensen K,Kristensen AT,Pyke C,Røjkjaer R,Persson E

    更新日期:2003-11-15 00:00:00

  • Eosinophilic cytoplasmic inclusions in fetal leukocytes: are Auer bodies a recapitulation of fetal morphology?

    abstract::Among the most striking morphological features of acute nonlymphoblastic leukemias (ANLL) is the occurrence of eosinophilic cytoplasmic inclusions known as Auer rods on Auer bodies. We examined immature myeloid cells from the peripheral blood of 9 human fetuses of 16-19 wk gestation for the presence of such structures...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Newburger PE,Novak TJ,McCaffrey RP

    更新日期:1983-03-01 00:00:00

  • Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress.

    abstract::Ferroportin (FPN), the only known vertebrate iron exporter, transports iron from intestinal, splenic, and hepatic cells into the blood to provide iron to other tissues and cells in vivo. Most of the circulating iron is consumed by erythroid cells to synthesize hemoglobin. Here we found that erythroid cells not only co...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-04-842997

    authors: Zhang DL,Ghosh MC,Ollivierre H,Li Y,Rouault TA

    更新日期:2018-11-08 00:00:00